Ovid Therapeutics
OVID
OVID
59 hedge funds and large institutions have $65.5M invested in Ovid Therapeutics in 2022 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 18 increasing their positions, 18 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
59
Holders Change
+4
Holders Change %
+7.27%
% of All Funds
1.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
18
Reduced
18
Closed
6
Calls
$52K
Puts
–
Net Calls
+$52K
Net Calls Change
-$64K
Top Buyers
Top Sellers
1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$3.58M |
2 |
D.E. Shaw & Co
New York
|
-$364K |
3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$224K |
4 |
First Trust Advisors
Wheaton,
Illinois
|
-$174K |
5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$138K |